Abstract-Protein nitration and lipid peroxidation are implicated in the pathogenesis of atherosclerosis; however, neither the cellular mediators nor the reaction pathways for these events in vivo are established. In the present study, we examined the chemical pathways available to monocytes for generating reactive nitrogen species and explored their potential contribution to the protein nitration and lipid peroxidation of biological targets. Isolated human monocytes activated in media containing physiologically relevant levels of nitrite (NO 2 Ϫ ), a major end product of nitric oxide (
O xidative damage of LDL is thought to be a critical step in atherogenesis. [1] [2] [3] [4] Accordingly, both the ability of cells present in the artery wall to accelerate LDL oxidation and the mechanisms through which cells generate reactive intermediates are currently of great interest. One pathway for LDL modification in vivo is through reactive nitrogen species. Immunohistochemical studies demonstrate that nitrotyrosine, a global marker of protein damage by nitrating intermediates, is increased in human atherosclerotic intima. 5 Moreover, mass spectrometric studies demonstrate that the nitrotyrosine content of LDL recovered from human atherosclerotic aortas is nearly 100-fold higher than that observed in circulating LDL from healthy donors. 6 We recently demonstrated that myeloperoxidase (MPO), a heme protein enriched in human atherosclerotic lesions, can generate nitrating intermediates that convert LDL into a high-uptake form for macrophages. 7 However, characterization of the role of MPO versus other pathways in monocytes to generate reactive nitrogen species has not yet been examined. Despite a wealth of evidence that reactive nitrogen species contribute to protein and lipoprotein modification during vascular disease, neither the cellular sources of nitrating intermediates nor the reaction pathways for their generation in vivo are established.
Multiple cells present in the vasculature (eg, macrophages, endothelial cells) are capable of generating nitric oxide (
• NO), a long-lived free radical with potent biological activ-ities. 8 • NO is a weak reducing agent and does not react with most biological targets; however, a variety of reactive nitrogen species derived from • NO are powerful oxidants, and they may contribute to oxidative damage. 9 -11 The cellular sources of reactive nitrogen species in atherosclerotic tissues is not established. It is generally assumed, however, that monocytes play a role in their production. Monocytes can be stimulated with various cytokines and vasoactive hormones to produce • NO by upregulating expression of the inducible isoform of nitric oxide synthase (NOS) (reviewed in Reference 12) . Monocytes also undergo a respiratory burst after activation by a variety of agonists, producing reduced oxygen species such as superoxide (O 2 •Ϫ ) and hydrogen peroxide (H 2 O 2 ). 13, 14 Hence, it has been concluded that monocytes may generate peroxynitrite (ONOO Ϫ ), a potent nitrating oxidant formed by the interaction of
• NO and O 2 •Ϫ . 5, 6, 9 Despite the fact that monocytes are thought to play an essential role in both atherogenesis 15 and the generation of reactive nitrogen species in vascular tissues, [1] [2] [3] [4] 16, 17 the chemical pathways available to monocytes for generating
• NOderived oxidants have not yet been directly examined. Indeed, no reports to date demonstrate that monocytes can promote the nitration of free or protein-bound tyrosine residues. Moreover, enhanced
• NO production by peritoneal macrophages 16 or from an exogenous source 18, 19 has been reported to inhibit rather than augment the extent of LDL lipid peroxidation. Thus, direct examination of the pathways available to monocytes for generating reactive nitrogen species and the characterization of the conditions under which they participate in protein and lipid modification must be addressed.
Studies thus far into the pathways available for LDL modification by reactive nitrogen species have relied primarily on in vitro chemical systems, neutrophils, and exogenous
• NO generating systems. On the basis of these studies, at least 3 distinct pathways for generating reactive nitrogen species have been suggested. The first involves formation of ONOO Ϫ through the interaction of • NO and O 2 •Ϫ . 9 The exposure of LDL to ONOO Ϫ results in the nitration of apolipoprotein B-100 (apo B-100) tyrosine residues, 6 the initiation of lipid peroxidation, 20, 21 and the depletion of lipid-soluble antioxidants. 22, 23 The incubation of LDL with millimolar concentrations of ONOO Ϫ results in lipoprotein aggregation and conversion into a high uptake form for macrophages. 7, 24 In the presence of CO 2 , ONOO Ϫ forms a more potent nitrating intermediate, presumably nitrosoperoxocarbonate (ONOOCO 2 Ϫ ). 25 At physiological concentrations of CO 2 , the yield of ONOO Ϫ -mediated nitration reactions is increased, apparently through formation of this adduct (reviewed in Reference 26) . The formation of ONOO Ϫ is shown in the following equation:
Two alternative pathways for generating reactive nitrogen species were recently described; they each involve MPO, a protein secreted by neutrophils and monocytes. [27] [28] [29] [30] Immunohistochemical studies demonstrate that MPO is abundant in human atherosclerotic lesions. 31 LDL recovered from human atheromas is enriched in chlorotyrosine, a specific product of MPO-generated hypochlorous acid (HOCl). 32 Antibodies specific for nitrotyrosine recognize epitopes in human atheroma that colocalize with mononuclear phagocytic cells, 5 which are similar to MPO. 31 Recent studies demonstrate that isolated MPO can use nitrite (NO 2 Ϫ ), a major end product of • NO metabolism, 11, 33 as a substrate to nitrate protein tyrosine residues 7, 28, 29 and initiate lipid peroxidation. 7, 34 LDL exposed to the MPO-H 2 O 2 -NO 2 Ϫ system is converted into a high-uptake form for macrophages, leading to cholesterol deposition and foam cell formation, 7 essential steps in atherogenesis. The reactive nitrogen species formed during MPO-catalyzed oxidation of NO 2 Ϫ have not yet been identified, but nitrogen dioxide (
• NO 2 ), the one-electron oxidation product of NO 2 Ϫ , has been implicated. 28 Finally, MPO may also indirectly generate a nitrating intermediate through the secondary oxidation of NO 2 Ϫ with HOCl, presumably forming nitryl chloride (NO 2 Cl). 27 Exposure of LDL to NO 2 Cl causes lipoprotein aggregation and conversion into a phagocytosable particle for macrophages. 35 Despite the ability of monocytes to undergo a respiratory burst, to generate • NO, and to secrete MPO when activated, direct evidence that monocytes can generate reactive nitrogen species that promote LDL nitration and lipid peroxidation is lacking. Equations for the chemical reactions discussed above follow:
In the present study, we examined the various chemical pathways available to monocytes for generating reactive nitrogen species. Mechanisms for the monocyte-dependent formation of nitrating intermediates and characterization of the ability of these distinct pathways to promote LDL protein nitration and initiate LDL lipid peroxidation are presented. Finally, we examined the role of
• NO production rates on the relative contribution of distinct pathways in activated monocytes for promoting apo B-100 nitration and LDL lipid peroxidation. 
Materials and Methods

Materials
Methods
General Procedures
All buffers and media were treated with Chelex-100 resin (Bio-Rad) and supplemented with diethylenetriaminepentaacetic acid (DTPA) to remove trace levels of potential redox-active transition metal ions. 40 Actual rates of NO flux were then determined spectrophotometrically by the reaction of NO with oxyhemoglobin 41 under the same conditions used for experiments but in the absence of any added cells. To maintain a final pH of 7.4 during experiments with PAPA NONOate, incubations were performed in medium B (medium A containing only 100 mmol/L NaCl and supplemented with 20 mmol/L sodium phosphate).
Pilot experiments revealed that detectable levels of F 2 -isoprostanes were generated by monocytes in the absence of added NO 2 Ϫ , but only at a level Ϸ20% of that observed in the presence of NO 2
Ϫ
. This was presumably due to prostaglandin endoperoxide synthase activity, because the reaction was inhibited by aspirin and dexamethasone and not inhibited by superoxide dismutase (SOD), aminotriazole, or butylated hydroxytoluene. Thereafter, in all experiments in which F 2 -isoprostane production was measured, the contribution of prostaglandin endoperoxide synthase-1 and -2 to eicosanoid production was suppressed by including aspirin (10 g sodium salicylate/mL) and dexamethasone (2 mol/L), respectively, in reaction mixtures before monocyte stimulation. 42 
Sample Preparation and Mass Spectrometric Analyses
Nitrotyrosine content was determined by stable isotope dilution gas chromatography-mass spectrometry (GC/MS) on a Finnigin Voyager quadrupole GC/MS equipped with a chemical ionization probe. 3-[ 13 C 6 ]nitrotyrosine was synthesized and used as an internal standard, as previously described. 6 Briefly, reactions were terminated by forming cell pellets and adding butylated hydroxytoluene. Lipids and salts were removed by extraction with a single-phase solvent mixture of H 2 O:water-washed diethyl ether:methanol (1:3:7, vol:vol:vol). 43 Internal standards were then added, samples were hydrolyzed with HCl, and the nitrotyrosine content in amino acid hydrolysates was determined after reduction to amino tyrosine as an n-propyl, per heptafluorobutyryl derivative. 44 Nitrotyrosine content was normalized to the content of tyrosine determined by stable isotope dilution GC/MS 45 using [ 2 H 4 ]-labeled tyrosine as the standard. Under the conditions used, no significant intrapreparative formation of nitrotyrosine, which was routinely assessed in each sample by determining the 3-[ 2 H 3 ]-nitrotyrosine present, occurred. For 9-hydroxy-10,12-octadecadienoate/9-hydroperoxy-10,12-octadecadienoate acid (9-H[P]ODE) and F 2 -isoprostane determinations, hydroperoxides in reaction mixtures were reduced to their corresponding stable hydroxides during extraction using a modified Dole procedure in which the reducing agent, triphenylphosphine, was present. 46 These conditions also inhibited artifactual formation of F 2 -isoprostanes and oxidized lipids. 47 Lipids were dried under N 2 and resuspended in isopropanol (2 mL); then, fatty acids were released by base hydrolysis with 1N sodium hydroxide (2 mL) at room temperature under N 2 for 90 minutes. The samples were acidified (pH 3.0) with 2N HCl, known amounts of internal standards were added, and free fatty acids were extracted twice with hexane (5 mL). The content of 9-H(P)ODEs and F 2 -isoprostanes were then determined by HPLC with online tandem mass spectrometric (LC/ MS/MS) analysis. Control experiments using [ 3 H]arachidonate confirmed that no detectable formation of [ 3 H]-labeled 9-H(P)ODE or F 2 -isoprostanes occurred under the conditions used for sample preparation.
LC/MS/MS analyses were performed on a Quatro II triple quadruple mass spectrometer (Micromass, Inc) interfaced with an HP 1100 HPLC (Hewlett Packard). F 2 -isoprostanes were quantified by stable isotope dilution mass spectrometry using online reverse-phase LC/MS/MS with 8-epi-[ 2 H 4 ]PGF 2␣ as the standard. 48 For 9-HODE analyses, lipid extracts generated after base hydrolysis of reduced lipids (above) were dried under N 2 and reconstituted in 100 L of methanol. An aliquot of the mixture was then injected on an Ultrasphere ODS C18 column (4.6ϫ250 mm, 5 m, Beckman Instruments), equilibrated, and run under isocratic conditions at 1 mL/min using methanol:H 2 O, (85:15, vol/vol) as the solvent. The column eluent was split (930 L/min to UV detector and 70 L/min to mass detector) and analyzed by the mass spectrometer. The LC/MS/MS analyses of 9-HODE and F 2 -isoprostanes in column effluents were performed using electrospray-ionization mass spectrometry in the negative-ion mode with multiple-reaction monitoring and monitoring the transitions at mass per unit charge (m/z) 2953171 for 9-HODE, m/z 3533309 for F 2 -isoprostanes, and m/z 3573313 for [ 2 H 4 ]PGF 2␣ . The endogenous content of 9-H(P)ODE in samples was initially determined by the method of standard additions using known amounts of authentic 9-HODE added to samples. Quantification in subsequent experiments was done using external calibration curves constructed with authentic 9-HODE after preliminary LC/MS/MS experiments demonstrating results identical to those obtained by the method of standard additions.
Statistics
Statistical analyses were done using a paired Student's t test. For all hypotheses, the significance level was 0.05. When multiple comparisons were made, a Bonferroni correction to the significance criterion for each test was done.
Results
LDL Protein Nitration and Lipid Peroxidation Are Mediated by the MPO-H 2 O 2 -NO 2 ؊ System of Monocytes
Fresh peripheral blood monocytes were activated with PMA in Chelex-100 -treated media containing the metal chelator DTPA and LDL, and the extent of LDL modification by reactive nitrogen species was determined by stable isotope dilution GC/MS analysis of apo B-100 nitrotyrosine content. In parallel, the ability of monocyte-generated reactive nitrogen species to initiate lipid peroxidation was assessed by quantifying the oxidation products of linoleic acid (9-H(P)ODE) and arachidonic acid (F 2 -isoprostanes) by LC/MS/ MS. Under these conditions, monocyte activation failed to promote protein nitration or lipid peroxidation of LDL. In contrast, adding NO 2 Ϫ to the monocyte reaction mixtures at concentrations comparable to those observed in inflammatory tissues and fluids (See Reference 28 and the references therein) induced the nitration of apo B-100 tyrosine residues and initiated LDL lipid peroxidation (Figure 1 ). The time course for tyrosine nitration and lipid peroxidation paralleled the time course for O 2
•Ϫ production and was maximal by Ϸ120 minutes (data not shown). Tyrosine nitration and lipid peroxidation by monocytes required cell activation and were inhibited by the presence of peroxidase inhibitors (NaN 3 and aminotriazole). Moreover, adding catalase, but not heat-inactivated catalase, effectively blocked nitrotyrosine, 9-H(P)ODE, and F 2 -isoprostane production ( Figure 1 ).
Monocytes activated with N-formyl-methionyl-leucylphenylalanine (100 nmol/L) similarly demonstrated NO 2 Ϫ -dependent LDL tyrosine nitration and lipid peroxidation, albeit at a level Ϸ6-to 8-fold less (2 fmol O 2
•Ϫ /cell over a 2-hour interval) than that observed with monocytes stimulated with PMA (12 fmol O 2
•Ϫ /cell over a 2-hour interval), which is consistent with the findings that both O 2
•Ϫ production and MPO secretion are decreased in monocytes stimulated with this agonist. Finally, the addition of methionine, a potent scavenger of chlorinating oxidants like HOCl and NO 2 Cl, failed to significantly attenuate the extent of tyrosine nitration and lipid peroxidation induced by the activated monocytes (Figure 1 ). These results suggest that secondary oxidation of NO 2 Ϫ by HOCl (eg, Equation 3) was not a significant pathway for reactive nitrogen species formation by the activated monocytes.
Interestingly, adding either SOD or heat-inactivated SOD to the reaction mixture did not attenuate protein nitration or lipid peroxidation by the cells, suggesting that O 2
•Ϫ (and hence ONOO Ϫ ; Equation 1) does not play a direct role in LDL oxidation by human peripheral blood monocytes under the conditions examined. Rather, adding SOD to the activated cells resulted in a modest increase (Ϸ50%) in the production of markers of lipid peroxidation (Figure 1 ). Control experiments suggested that SOD itself was not directly promoting lipid peroxidation because the addition of both SOD and peroxidase inhibitors (ie, NaN 3 , NaCN, or aminotriazole) to cells activated in the presence of NO 2 Ϫ resulted in no significant formation of lipid oxidation products (data not shown). The mechanism(s) responsible for the increased extent of lipid peroxidation observed in the presence of SOD are unknown, but they may reflect the prevention of O 2
•Ϫ -dependent conversion of MPO into an inactive form (ie, Compound III) 49 Ϫ . Thus, monocyte activation in vivo will likely produce nitrating intermediates at both normal and pathophysiologically relevant concentrations of NO 2 Ϫ through the MPO-H 2 O 2 -NO 2 Ϫ system.
Monocytes Generate • NO-Derived Oxidants
One striking feature of the results described thus far was that we could find no evidence that isolated monocytes generate nitrating intermediates through the formation of ONOO Ϫ (Equation 1), because both nitrotyrosine formation and lipid peroxidation required the addition of NO 2 Ϫ to the media (Figures 1 through 3) . This likely reflects the limited capacity of freshly isolated peripheral blood monocytes to generate Additions or deletions to the Complete System were as indicated. Reactions were stopped by removing cells through centrifugation. Left, Content of nitrotyrosine (NY) in LDL was then determined by stable-isotope dilution GC/MS, as described in Materials and Methods. Middle, Lipids in supernatants were extracted, reduced, and hydrolyzed, and content of total (freeϩlipid-bound) 9-H(P)ODE was determined. Right, F 2 -isoprostanes were then determined by LC/MS/MS, as described in Materials and Methods. Final concentrations of additions to Complete System were 1 mmol/L NaN 3 , 10 mmol/L 3-aminotriazole (Atz), 300 nmol/L catalase (Cat), 300 nmol/L heat-inactivated catalase (hiCat), 100 mol/L methionine (Met), 10 g/mL SOD, and 10 g/mL heat-inactivated SOD (hiSOD). Data represent meanϮSD of triplicate determinations. *PϽ0.05 for comparison vs Complete System. Y indicates tyrosine.
• NO, the brief time period used for LDL incubation with monocytes (ie, 2 hours, the approximate duration of O 2
•Ϫ formation after a PMA-stimulated respiratory burst), and the presence of metal chelators in cell culture media to prevent lipid peroxidation mediated by trace levels of redox-active transition metal ions. Indeed, we were unable to detect any endogenous rate of NO production (or NO 2 Ϫ /NO 3 Ϫ accumulation) in human monocytes freshly isolated from peripheral blood, with or without phorbol ester activation, under the conditions and time course (2 hours) used. To more fully explore the chemical mechanisms available to monocytes for generating reactive nitrogen species, we performed a series of experiments in which monocytes were activated in the presence of an exogenous
• NO-generating system, PAPA NONOate. 40 These conditions were expected to more closely mimic a physiological mechanism for NO 2 Ϫ formation and to provide an environment in which monocyte-generated O 2
•Ϫ might react with
• NO before it dismutates into the MPO substrate H 2 O 2 .
Although monocytes activated in the absence of the • NO donor failed to nitrate apo B-100 tyrosine residues or to produce detectable levels of the products of lipid peroxidation (ie, 9H(P)ODE and F 2 -isoprostanes), cells stimulated in the presence of a continuous
• NO source readily promoted LDL protein ( Figure 4 ) and lipid ( Figure 5 ) modification. Protein nitration and lipid peroxidation by monocytes required cell activation, which is consistent with a requirement for reduced oxygen species (O 2 •Ϫ and/or H 2 O 2 ) for lipoprotein oxidation (data not shown). At higher fluxes of • NO, the overall extent of nitrotyrosine formation and lipid peroxidation diminished (Figures 4 and 5) . Taken together, the present results demonstrate that activated monocytes generate
• NO-derived oxidants that can damage protein and lipid targets.
Monocytes Use Distinct Pathways for Generating • NO-Derived Oxidants
At low rates of
• NO flux, LDL protein nitration (Figure 6 , top) and lipid peroxidation (Figure 7 , top) were inhibited by either catalase or azide. In contrast, under these conditions, the addition of either HOCl scavengers (eg, methionine or N␣-acetyl lysine) or SOD failed to significantly attenuate nitrotyrosine or 9-H(P)ODE production ( Figure 6 , bottom, and Figure 7 , bottom, respectively). These results suggest that at low rates of Ϫ in absence (F) and presence (E) of 300 nmol/L catalase (Cat) in medium A for 2 hours at 37°C. Reactions were stopped by removing cells through centrifugation. Lipids in supernatants were extracted, reduced, and hydrolyzed. Then, content of (top) total (freeϩlipid-bound) 9-H(P)ODE and (bottom) F 2 -isoprostanes were determined by LC/MS/MS, as described in Materials and Methods. Data represent meanϮSD of triplicate determinations.
partially attenuated the extent of nitrotyrosine and 9-H(P)ODE produced at high levels of
• NO flux, the mechanism does not seem to be due to the consumption of NO 2 Cl or HOCl. Adding a primary amine (N␣-acetyl lysine) that also reacts rapidly with reactive chlorinating species like HOCl and NO 2 Cl to form monochloramines, 52,53 agents which do not promote the secondary oxidation of NO 2 Ϫ , 29 failed to inhibit either nitrotyrosine production or LDL lipid peroxidation by activated monocytes (Figure 6 , bottom, and Figure 7 , bottom, respectively). Taken together, the present results indicate that monocytes use distinct pathways for generating
• NO-derived oxidants.
Discussion
Reactive nitrogen species are implicated in many inflammatory and vascular disorders. Because of the ability of monocytes to generate both 17 The present studies demonstrated that monocytes use distinct mechanisms for generating reactive nitrogen interme- Figure 4 . Nitration of apo B-100 tyrosine residues by monocyte-generated
• NO-derived oxidants. LDL (0.2 mg/mL) was incubated for 2 hours at 37°C with phorbol ester (200 nmol/L) stimulated human monocytes (10 6 cells/mL) in presence of increasing rates of
• NO release from PAPA NONOate, as described in Materials and Methods. Reactions were stopped by removing cells through centrifugation. Content of nitrotyrosine formed in LDL was then determined by stable-isotope dilution GC/MS, as described in Materials and Methods. Data represent meanϮSD of triplicate determinations. • NO-derived oxidants. LDL (0.2 mg/mL) was incubated for 2 hours at 37°C with phorbol ester (200 nmol/L) stimulated human monocytes (10 6 cells/mL) in presence of increasing rates of
• NO release from PAPA NONOate, as described in Materials and Methods. Reactions were stopped by removing cells through centrifugation. Lipids in supernatants were extracted, reduced, and hydrolyzed, and content of total (freeϩ lipid-bound) 9-H(P)ODE formed was then determined by LC/MS/ MS, as described in Materials and Methods. Data represent meanϮSD of triplicate determinations. • NO release from PAPA NONOate, as described in Figure 4 (control condition). In parallel reactions, cells were also incubated with indicated addition. Reactions were stopped by removing cells through centrifugation, and content of nitrotyrosine formed in LDL was then determined by stable-isotope dilution GC/MS, as described in Materials and Methods. Data represent meanϮSD of triplicate determinations and are expressed as percent of nitrotyrosine formed in presence of indicated addition relative to level of nitrotyrosine formed under control conditions. Similar results were observed in 3 independent experiments. Concentration of additives, when present, were as follows: 300 nmol/L catalase (Cat), 1 mmol/L NaN 3 , 1 mmol/L N␣-acetyl lysine (N␣-AcLys), 1 mmol/L methionine (Met), and 10 g/mL SOD.
diates. They also demonstrated that the environment in which monocyte activation occurs (eg, level of
• NO) influences the relative contribution that distinct oxidation pathways play in contributing to protein nitration and lipid peroxidation. On the basis of the results from the present report and prior published studies, we generated the following model ( Figure  8 ) of pathways available to monocytes for promoting LDL modification by reactive nitrogen species. On activation, the NADPH oxidase complex of monocytes forms O 2 •Ϫ , which both spontaneously and enzymatically (through SOD) dismutates to form H 2 O 2 . 13 Concomitantly, monocyte activation leads to the secretion of MPO into the extracellular compartment (and into the phagolysosomal compartment; not shown). 53 Under conditions of relatively low levels of • NO flux, the primary pathway used by monocytes for generating reactive nitrogen intermediates is through MPO/ H 2 O 2 -catalyzed oxidation of NO 2 Ϫ (Figure 8, pathway A) . The ability of monocytes to use this pathway is strongly supported by the demonstration that both activated monocytes (this study) and isolated MPO 7 use physiological concentrations of NO 2 Ϫ to nitrate apo B-100 tyrosine residues and initiate LDL lipid peroxidation. The ability of MPO inhibitors (NaN 3 , NaCN, and aminotriazole) and H 2 O 2 scavengers (catalase) to block nitrotyrosine (Figures 1 and 6 ), It is interesting to note that the overall yields of nitration and lipid peroxidation dropped at higher fluxes of
• NO (Figures 4 and 5) . Several mechanism(s) may account for these results. One likely reason is that • NO may partially act as an • NO release from PAPA NONOate, as described in Figure 5 (control condition) . In parallel reactions, cells were also incubated with indicated addition. Reactions were stopped by removing cells through centrifugation. Lipids in supernatants were extracted, reduced, and hydrolyzed, and content of total (freeϩlipid-bound) 9-H(P)ODE formed was then determined by LC/MS/MS, as described in Materials and Methods. Data represent meanϮSD of triplicate determinations and are expressed as percent of total 9-H(P)ODE formed in presence of indicated addition relative to level formed under control conditions. Concentration of additives, when present, were as follows: 300 nmol/L catalase (Cat), 1 mmol/L NaN 3 , 1 mmol/L N␣-acetyl lysine (N␣-AcLys), 1 mmol/L methionine (Met), and 10 g/mL SOD. antioxidant under these conditions by scavenging reactive intermediates though radical-radical interactions. 55 Ϫ by MPOgenerated HOCl is reported as a mechanism for MPO-and neutrophil-mediated nitrotyrosine formation, 27 ,29 the present results failed to demonstrate a role for this pathway (Figure 8 , pathway B) in the monocyte-dependent formation of nitrating agents. Specifically, neither the extent of apo B-100 nitrotyrosine formation nor the content of F 2 -isoprostanes and 9-H(P)ODE formed during exposure of LDL to activated monocytes and NO 2 Ϫ was blocked by the addition of the HOCl scavenger methionine (Figure 1) . Moreover, monocyte activation in the presence of an
• NO donor and N␣-acetyl lysine, which rapidly reacts with HOCl and NO 2 Cl to form monochloramines, failed to inhibit LDL nitration and lipid peroxidation ( Figures 6 and 7, bottom) . Whether this pathway contributes to reactive nitrogen species formation by monocytes activated under alternative conditions remains unknown.
An important consideration is the concentrations of NO 2 Ϫ , • NO, and CO 2 -HCO 3 Ϫ used in the present study. Although the actual levels of NO 2 Ϫ present in tissues such as the arterial intima are not known, NO 2 Ϫ levels of Յ5 mol/L are normally present in plasma, and levels as high as 50 mol/L have been observed in numerous biological fluids during inflammation (See Reference 28 and references therein). Thus, the present results demonstrate that monocytes use biologically relevant levels of NO 2 Ϫ to promote protein nitration and lipid peroxidation (Figures 2 and 3) . Similarly, a wide range of steady-state levels of Intra-and extracellular concentrations of CO 2 and HCO 3 Ϫ in humans are typically 1 to 2 mmol/L and 7 to 25 mmol/L, respectively. 56 At these levels, a significant portion of the reactivity of ONOO Ϫ in solution is attributable to ONO-OCO 2 Ϫ . [25] [26] [27] 57 Although the levels of CO 2 (5% gas phase) and HCO 2 Ϫ in the media (4.2 mmol/L) used in these studies more closely mimic a biologically relevant situation, the proximate oxidant in reactions mediated by the product of
• NO and O 2
•Ϫ (Figure 8 , pathway C) is not easily established (ONOO Ϫ versus ONOOCO 2 Ϫ or a combination of the two). A significant finding of the present study is the demonstration that alternative pathways to ONOO Ϫ formation can play a significant-and even predominant-role in oxidative injury of biomolecules by monocyte-generated nitrating intermediates. One practical consequence is that efforts to block oxidative injury in vivo by
• NO-derived oxidants will require the use of distinct pharmacological agents that block distinct pathways. For example, agents such as SOD mimetics, which can compete with
•Ϫ and inhibit ONOO Ϫ formation, may serve to paradoxically enhance nitration and lipid peroxidation reactions through the MPO-H 2 O 2 -NO 2 Ϫ pathway. It is known that nitrotyrosine is present in a variety of tissues and conditions. What remains is to determine the functional consequences of protein and lipid modification by nitrating oxidants in vivo and to identify which factors influence the relative contributions of various mechanisms for generating
• NO-derived oxidants during human health and disease.
